Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Filings indexed 422 across all filing types
Latest filing 2021-02-10 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to employees, including the number of shares, exercise price, vesting conditions, and the board's resolution. This type of disclosure regarding changes in capital structure and equity-based compensation for employees/directors is classified as a 'Share Issue/Capital Change' (SHA) in the provided taxonomy, as it relates to the potential issuance of new shares or treasury shares.
2021-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details specific changes to the number of shares and the list of recipients for stock options. In the context of financial filings, announcements regarding the issuance, modification, or cancellation of stock options (share-based compensation) are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's capital structure and equity-linked instruments.
2021-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previous filing for 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details specific changes to the number of shares and the list of recipients due to cancellations. In the context of financial filings, reports concerning the issuance of stock options or changes to capital structure/share-based compensation are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's equity structure and potential future share dilution.
2021-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previous 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted, the number of recipients, and the total status of stock options after cancellation. This type of filing, which relates to the issuance or modification of equity-based compensation instruments, falls under the category of 'Share Issue/Capital Change' (SHA) as it pertains to changes in the company's capital structure and equity obligations.
2021-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Handok Inc. regarding a correction to a previously filed 'Report on Granting Stock Options' (주식매수선택권 부여에 관한 신고). It details specific changes to the number of shares and the list of recipients for stock options. Since this is a formal regulatory disclosure regarding changes to equity-based compensation and capital structure, it falls under the 'Regulatory Filings' category as it is a specific corporate announcement that does not fit into the other specialized categories like 'Director's Dealing' or 'Share Issue'.
2021-02-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares granted and the list of recipients. In the context of Korean regulatory filings (DART), this is a specific corporate disclosure regarding capital structure and employee compensation via stock options. Since it involves changes to share-based compensation and capital issuance, it falls under the 'Share Issue/Capital Change' category.
2021-02-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.